A database integrating long-term respiratory data with natural history data from people with amyotrophic lateral sclerosis (ALS) has been made available to scientists globally, with the hopes of ...

Oliveira presents just one half of the offensive problem the Als have to deal with. Quarterback Zach Collaros has completed the most passes of his career this season with 318 and can set a new ...

Neither memantine nor trazodone, two medications approved to treat other conditions, was able to slow disease progression in people with amyotrophic lateral sclerosis (ALS) who took part ... versus ...

Sweatshirts, hot drinks, you name it. When you think of ALS, you think despair, decay, doom. But if you follow Eby on social media like TikTok and Instagram, you're likely fighting off fits of ...

return false; // Move randomly } "It’s crucial to emphasize that while these movement functions are implemented in software, the decision to use one or the other is driven by the brain organoid’s ...

A new drug called Ellorarxine is offering hope to those suffering from motor neurone disease (MND), according to a recent study published in the International Journal of Molecular Sciences.

By focusing on sporadic ALS — which encompasses 90-95% of all cases — this patent provides us with protection for the use of fasudil in the vast majority of the population affected by this ...

SAVANNAH, GEORGIA — Current disease-modifying therapies for amyotrophic lateral sclerosis (ALS) don’t extend lifespans by much, but several drug options are available, nerve specialists learned.